Contact this trialFirst, we need to learn more about you.
Chemotherapy
Chemoradiation + Pembrolizumab/Lenvatinib for Esophageal Cancer
Recruiting1 awardPhase 2
Duarte, California
This trial is studying the effect of giving chemoradiation and pembrolizumab followed by pembrolizumab and lenvatinib before surgery to treat patients with esophageal or esophageal/gastroesophageal junction cancer that has not spread to other places in the body.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service